S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
TXG · 10x Genomics, Inc. Class A
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
10X Genomics Inc (TXG)
NASDAQ NMS - GLOBAL MARKET
Life Sciences Tools & Services
$75.48
+4.09
(+5.72%)
● At close: October 21 at 4:00:00 PM EDT
$75.00
-0.59
(-0.78%)
Overnight:
9:43:22 PM EDT
DAY'S RANGE
$75.48
$70.24
$77.48
52-WEEK RANGE
$75.48
$11.87
$102.81
What's happening
- TXG is up 5.72% today, trading at $75.48. — Live quote
- Volume today (229,353) is well below its 3-month average of 3,359,280. (Finnhub fundamentals)
- Reports earnings on 2026-11-05 (after market close), 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.14 actual vs. $-0.25 estimated (+43.1%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 6
Buy 4
Hold 12
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (22 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
TXG
+338.14%
vs S&P 500
+325.36%
1-YEAR RETURN
TXG
+443.84%
vs S&P 500
+429.27%
6-MONTH RETURN
TXG
+183.12%
3-MONTH RETURN
TXG
+51.40%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.14
Est. $-0.25
BEAT +43.1%
2026-04-26 (Q1 2026)
$-0.10
Est. $-0.29
BEAT +66.0%
2026-01-26 (Q4 2025)
$-0.13
Est. $-0.21
BEAT +39.4%
2025-10-26 (Q3 2025)
$-0.22
Est. $-0.29
BEAT +24.4%
Valuation Measures & Ratios
Enterprise Value4$8.88B
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)15.21
Price / Book75.90
EV4 / Revenue14.40
EV4 / EBITDA—
Profit Margin-12.18%
Operating Margin-14.33%
Return on Equity (ROE8)-9.33%
Return on Assets (ROA9)-7.30%
Avg Volume (3M)3,359,280
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $4.91B | $2.86B | $1.46B | $1.43B | $1.07B |
| P/E | -201.89 | -70.12 | -23.15 | -19.43 | -6.38 |
| Price/Sales | 7.88 | 4.55 | 2.32 | 2.26 | 1.78 |
| Price/Book | 5.95 | 3.51 | 1.86 | 1.85 | 1.52 |
| EV/Revenue | 7.88 | 4.55 | 2.32 | 2.26 | 1.78 |
| EV/EBITDA | -4992.98 | -127.61 | -30.52 | — | — |
| ROE | -2.95% | -5.01% | -8.03% | -9.50% | -23.76% |
| ROA | -2.36% | -4.01% | -6.14% | -7.50% | -18.59% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short15,371,598
Change from Prior Settlement-7.91%
% of Float—
Days to Cover (Short Ratio)4.53
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Trailing 52-week price return is +443.8%. Finnhub market metrics ↗
- Latest SEC filing is Form 4, filed 2026-09-24; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -12.7% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -12.2%. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on TXG
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $151.0M | $150.8M | $149.0M | $172.9M | $154.9M | $151.7M | $153.1M | $141.0M |
| Gross profit | $112.5M | $106.2M | $100.3M | $125.1M | $105.4M | $106.4M | $104.2M | $92.9M |
| Operating income | -$19.6M | -$17.0M | -$32.2M | $30.1M | -$39.3M | -$41.5M | -$41.7M | -$61.5M |
| Net income | -$17.9M | -$13.5M | -$27.5M | $34.5M | -$34.4M | -$35.8M | -$37.9M | -$59.9M |
| EPS (diluted) | $-0.14 | $-0.10 | $-0.22 | $0.28 | $-0.28 | $-0.30 | $-0.32 | $-0.50 |
| EPS (basic) | $-0.14 | $-0.10 | $-0.22 | $0.28 | $-0.28 | $-0.30 | $-0.32 | $-0.50 |
| Operating margin | -$13 | -$11 | -$22 | $17 | -$25 | -$27 | -$27 | -$44 |
| Net margin | -$12 | -$9 | -$18 | $20 | -$22 | -$24 | -$25 | -$43 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.03B | $1.02B | $1.04B | $1.03B | $980.0M | $903.4M | $918.6M | $937.8M |
| Total liabilities | $204.5M | $201.4M | $245.0M | $242.2M | $206.7M | $196.5M | $208.5M | $215.0M |
| Stockholders' equity | $825.5M | $814.3M | $796.3M | $785.1M | $773.3M | $706.9M | $710.1M | $722.8M |
| Total current assets | $674.7M | $669.7M | $684.5M | $659.8M | $655.7M | $579.7M | $584.4M | $593.9M |
| Total current liabilities | $118.5M | $113.6M | $153.5M | $147.3M | $112.2M | $107.9M | $117.6M | $121.2M |
| Cash & equivalents | — | — | — | — | — | — | $344.1M | — |
| Accounts receivable | $47.5M | $39.0M | $47.0M | $43.8M | $50.0M | $52.5M | $87.9M | $83.5M |
| Inventory | $52.6M | $53.5M | $56.3M | $62.0M | $69.0M | $74.7M | $83.1M | $94.0M |
| Property, plant & equipment | $215.3M | $220.6M | $226.7M | $232.5M | $239.7M | $246.1M | $252.6M | $258.8M |
| Goodwill | $6.9M | $4.5M | $4.5M | $4.5M | $4.5M | $4.5M | $4.5M | $4.5M |
| Intangible assets | $61.2M | $59.9M | $62.3M | $64.8M | $14.7M | $15.2M | $15.7M | $16.1M |
| Other non-current assets | $15.3M | $2.6M | $2.9M | $1.9M | $2.7M | $2.3M | $4.1M | $4.9M |
| Accounts payable | $20.7M | $17.4M | $12.7M | $18.1M | $15.9M | $10.1M | $12.9M | $26.2M |
| Deferred revenue (current) | $23.6M | $24.3M | $23.9M | $22.1M | $21.4M | $20.9M | $20.7M | $17.8M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | $7.1M | $8.4M | $11.0M | $12.4M | $12.8M | $12.3M | $5.5M | $5.7M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $6.6M | $6.4M | $6.5M | $6.4M | $6.1M | $5.4M | $5.0M | $4.9M |
| Common stock & paid-in capital | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Retained earnings | -$1.54B | -$1.52B | -$1.51B | -$1.49B | -$1.47B | -$1.50B | -$1.47B | -$1.42B |
| Accumulated other comprehensive income (loss) | $77.0K | $114.0K | $225.0K | $138.0K | $220.0K | -$367.0K | -$493.0K | $32.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $17.0M | $26.1M | $40.8M | $43.2M | $17.7M | $34.4M | -$6.7M | $21.6M |
| Investing cash flow | -$7.7M | -$1.3M | -$1.8M | -$8.8M | -$939.0K | -$1.9M | -$51.6M | -$3.6M |
| Financing cash flow | $3.0M | -$8.4M | $2.2M | $617.0K | $3.5M | $422.0K | $4.5M | $156.0K |
| Free cash flow | $15.4M | $24.5M | $39.0M | $42.5M | $16.1M | $32.5M | -$9.5M | $17.8M |
| Capital expenditures | $1.6M | $1.6M | $1.8M | $687.0K | $1.6M | $1.9M | $2.7M | $3.9M |
| Depreciation & amortization | $9.7M | $10.0M | $10.1M | $10.3M | $7.8M | $8.0M | $8.8M | $9.0M |
| Share-based compensation | $25.6M | $22.6M | $25.2M | $25.3M | $27.6M | $31.1M | $32.5M | $33.6M |
| Deferred income taxes | -$1.4M | — | -$310.0K | — | $0 | — | $709.0K | — |
| Change in accounts receivable | $8.5M | -$8.0M | $3.2M | -$6.6M | -$2.6M | -$35.3M | $4.4M | -$7.7M |
| Change in inventory | -$3.0M | -$2.7M | -$5.6M | -$7.3M | -$7.0M | -$8.1M | -$9.6M | $4.3M |
| Change in accounts payable | $3.3M | $4.8M | -$5.4M | -$196.0K | $6.0M | -$2.5M | -$13.4M | $4.3M |
| Purchases of investments | $24.5M | $24.7M | $24.6M | $49.5M | $49.4M | $0 | $48.9M | $0 |
| Sales/maturities of investments | $25.0M | $25.0M | $25.2M | $50.0M | $50.0M | $0 | $0 | $0 |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $642.8M | $610.8M | $618.7M | $516.4M | $490.5M |
| Gross profit | $443.9M | $414.5M | $409.3M | $396.0M | $416.4M |
| Operating income | -$61.0M | -$194.6M | -$265.3M | -$167.9M | -$52.3M |
| Net income | -$43.5M | -$182.6M | -$255.1M | -$166.0M | -$58.2M |
| EPS (diluted) | $-0.35 | $-1.52 | $-2.18 | $-1.46 | $-0.53 |
| EPS (basic) | $-0.35 | $-1.52 | $-2.18 | $-1.46 | $-0.53 |
| Operating margin | -$9 | -$32 | -$43 | -$33 | -$11 |
| Net margin | -$7 | -$30 | -$41 | -$32 | -$12 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $1.04B | $918.6M | $965.1M | $1.03B | $1.02B |
| Total liabilities | $245.0M | $208.5M | $224.1M | $223.2M | $201.3M |
| Stockholders' equity | $796.3M | $710.1M | $741.0M | $805.7M | $817.6M |
| Total current assets | $684.5M | $584.4M | $596.0M | $635.0M | $747.6M |
| Total current liabilities | $153.5M | $117.6M | $127.2M | $131.0M | $110.4M |
| Cash & equivalents | — | $344.1M | $359.3M | $219.7M | $587.4M |
| Accounts receivable | $47.0M | $87.9M | $114.8M | $104.2M | $85.3M |
| Inventory | $56.3M | $83.1M | $73.7M | $81.6M | $60.0M |
| Property, plant & equipment | $226.7M | $252.6M | $279.6M | $289.3M | $169.5M |
| Goodwill | $4.5M | $4.5M | $4.5M | $4.5M | $4.5M |
| Intangible assets | $62.3M | $15.7M | $16.6M | $22.9M | $25.4M |
| Other non-current assets | $2.9M | $4.1M | $3.1M | $2.4M | $3.3M |
| Accounts payable | $12.7M | $12.9M | $15.7M | $21.6M | $17.4M |
| Deferred revenue (current) | $23.9M | $20.7M | $13.2M | $7.9M | $5.3M |
| Short-term debt | — | — | — | — | — |
| Other current liabilities | $10.9M | $5.5M | $4.4M | $6.7M | $8.3M |
| Long-term debt | — | — | — | — | — |
| Other non-current liabilities | $6.5M | $5.0M | $4.3M | $3.0M | $8.2M |
| Common stock & paid-in capital | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Retained earnings | -$1.51B | -$1.47B | -$1.28B | -$1.03B | -$863.3M |
| Accumulated other comprehensive income (loss) | $225.0K | -$493.0K | -$429.0K | -$4.3M | $22.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $136.1M | $6.7M | -$15.2M | -$33.6M | -$21.4M |
| Investing cash flow | -$13.4M | -$32.6M | $133.5M | -$350.9M | -$106.7M |
| Financing cash flow | $6.8M | $10.9M | $13.7M | $15.8M | $35.3M |
| Free cash flow | $130.1M | -$5.7M | -$63.8M | -$165.3M | -$122.7M |
| Capital expenditures | $5.9M | $12.4M | $48.6M | $131.7M | $101.3M |
| Depreciation & amortization | $36.2M | $35.9M | $35.5M | $25.4M | $21.1M |
| Share-based compensation | $109.1M | $140.7M | $166.9M | $136.8M | $96.0M |
| Deferred income taxes | -$310.0K | $709.0K | -$447.0K | $136.0K | -$690.0K |
| Change in accounts receivable | -$41.3M | -$27.0M | $10.6M | $18.9M | $34.0M |
| Change in inventory | -$28.0M | $9.8M | -$7.9M | $21.2M | $30.1M |
| Change in accounts payable | -$2.1M | -$3.4M | -$6.0M | $5.9M | $11.1M |
| Purchases of investments | $123.4M | $48.9M | $0 | $282.9M | $0 |
| Sales/maturities of investments | $125.2M | $25.8M | $82.8M | $18.5M | $0 |
| Share repurchases | — | — | — | — | — |
| Debt issued | — | — | — | — | — |
| Debt repaid | — | — | — | $0 | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding TXG as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers87.0%
Shares Outstanding120,203,444
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| FMR LLC | 17,629,266 | $675.9M | 14.67% | -0.6% | 2026-08-13 |
| BlackRock, Inc. | 10,804,070 | $414.2M | 8.99% | +7.2% | 2026-08-07 |
| ARK Investment Management LLC | 10,003,057 | $383.5M | 8.32% | -14.6% | 2026-08-14 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6,982,492 | $267.7M | 5.81% | +1.0% | 2026-06-30 |
| Quantinno Capital Management LP | 5,469,698 | $209.7M | 4.55% | +1.1% | 2026-08-13 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,082,594 | $194.9M | 4.23% | -3.5% | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4,539,007 | $174.0K | 3.78% | +2681.0% | 2026-08-14 |
| Sumitomo Mitsui Trust Group, Inc. | 4,194,627 | $160.8M | 3.49% | -17.9% | 2026-07-30 |
| Amova Asset Management Americas, Inc. | 4,192,517 | $160.7M | 3.49% | -17.9% | 2026-08-13 |
| Morgan Stanley | 3,351,911 | $128.5M | 2.79% | +26.2% | 2026-08-11 |
| Goldman Sachs Group Inc | 3,148,859 | $120.7M | 2.62% | -20.7% | 2026-08-14 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,082,790 | $118.2M | 2.56% | +6.1% | 2026-08-12 |
| State Street Corp | 2,801,437 | $107.4M | 2.33% | +8.2% | 2026-08-07 |
| CITADEL ADVISORS LLC | 2,779,213 | $106.6M | 2.31% | +273.7% | 2026-08-14 |
| DIMENSIONAL FUND ADVISORS LP | 2,225,284 | $85.3M | 1.85% | +8.9% | 2026-08-11 |
| AQR CAPITAL MANAGEMENT LLC | 2,026,464 | $74.7M | 1.69% | -20.2% | 2026-08-14 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,019,883 | $77.4M | 1.68% | -11.5% | 2026-08-12 |
| Point72 Asset Management, L.P. | 1,852,776 | $71.0M | 1.54% | +0.0% | 2026-08-14 |
| Capital World Investors | 1,493,031 | $57.2M | 1.24% | +2.8% | 2026-08-07 |
| T. Rowe Price Investment Management, Inc. | 1,266,954 | $48.6K | 1.05% | -1.0% | 2026-08-14 |
| Northern Trust Corp | 1,144,027 | $43.9M | 0.95% | +9.2% | 2026-08-12 |
| Nuveen, LLC | 1,124,633 | $43.1M | 0.94% | +79.7% | 2026-08-11 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,087,150 | $41.7M | 0.90% | -3.5% | 2026-08-14 |
| Casdin Capital, LLC | 1,050,000 | $40.3M | 0.87% | -53.8% | 2026-08-14 |
| Connor, Clark & Lunn Investment Management Ltd. | 988,320 | $37.9M | 0.82% | +5.3% | 2026-08-12 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-04-14 to 2026-09-22
Recent transactions
- Insiders have net sold 278,193 shares over the last 182 days, across 0 purchases and 38 sales.
- Most recent: SULIMAN SHEHNAAZ (Reporting person) — Open market sale of 292 shares on 2026-09-22.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)278,193 sh(38 txns)
Net Shares-278,193
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| SULIMAN SHEHNAAZ | Reporting person | Open market sale | 2026-09-22 | 292 |
| Saxonov Serge | Chief Executive Officer | Open market sale | 2026-09-22 | 1,000 |
| Taich Adam | Chief Financial Officer | Open market sale | 2026-09-09 | 1,206 |
| STUELPNAGEL JOHN R | Reporting person | Open market sale | 2026-09-03 | 7,012 |
| Hindson Benjamin J. | See Remarks | Open market sale | 2026-08-24 | 13,818 |
| Teichmann Sarah A. | Reporting person | Open market sale | 2026-08-14 | 2,273 |
| Popovits Kimberly J | Reporting person | Grant / award | 2026-06-04 | 8,829 |
| MATEO ALAN | Reporting person | Grant / award | 2026-06-04 | 8,829 |
| Kosaraju Sridhar | Reporting person | Grant / award | 2026-06-04 | 8,829 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-22 | SULIMAN SHEHNAAZ | Reporting person | Open market sale | 292 | $78.20 |
| 2026-09-22 | SULIMAN SHEHNAAZ | Reporting person | Open market sale | 614 | $79.51 |
| 2026-09-22 | SULIMAN SHEHNAAZ | Reporting person | Open market sale | 1,325 | $80.82 |
| 2026-09-22 | SULIMAN SHEHNAAZ | Reporting person | Open market sale | 2,270 | $81.67 |
| 2026-09-22 | SULIMAN SHEHNAAZ | Reporting person | Open market sale | 1,222 | $82.28 |
| 2026-09-22 | Saxonov Serge | Chief Executive Officer | Open market sale | 1,000 | $78.23 |
| 2026-09-22 | Saxonov Serge | Chief Executive Officer | Open market sale | 2,000 | $79.62 |
| 2026-09-22 | Saxonov Serge | Chief Executive Officer | Open market sale | 9,300 | $80.90 |
| 2026-09-22 | Saxonov Serge | Chief Executive Officer | Open market sale | 9,900 | $81.83 |
| 2026-09-22 | Saxonov Serge | Chief Executive Officer | Open market sale | 2,800 | $82.36 |
| 2026-09-09 | Taich Adam | Chief Financial Officer | Open market sale | 1,206 | $63.68 |
| 2026-09-09 | Taich Adam | Chief Financial Officer | Open market sale | 31,428 | $64.31 |
| 2026-09-09 | Taich Adam | Chief Financial Officer | Open market sale | 13,754 | $65.26 |
| 2026-09-03 | STUELPNAGEL JOHN R | Reporting person | Open market sale | 7,012 | $60.66 |
| 2026-09-03 | STUELPNAGEL JOHN R | Reporting person | Open market sale | 6,814 | $62.11 |
| 2026-09-03 | STUELPNAGEL JOHN R | Reporting person | Open market sale | 6,174 | $62.61 |
| 2026-09-01 | Saxonov Serge | Chief Executive Officer | Gift | 100 | $0.00 |
| 2026-08-26 | Saxonov Serge | Chief Executive Officer | Open market sale | 3,500 | $63.02 |
| 2026-08-26 | Saxonov Serge | Chief Executive Officer | Open market sale | 6,494 | $63.98 |
| 2026-08-26 | Saxonov Serge | Chief Executive Officer | Open market sale | 492 | $64.75 |
| 2026-08-24 | Saxonov Serge | Chief Executive Officer | Open market sale | 18,545 | $63.02 |
| 2026-08-24 | Taich Adam | Chief Financial Officer | Open market sale | 17,166 | $63.02 |
| 2026-08-24 | Hindson Benjamin J. | See Remarks | Open market sale | 13,818 | $63.02 |
| 2026-08-24 | SULIMAN SHEHNAAZ | Reporting person | Open market sale | 561 | $62.73 |
| 2026-08-24 | SULIMAN SHEHNAAZ | Reporting person | Open market sale | 1,646 | $63.97 |
| 2026-08-20 | Saxonov Serge | Chief Executive Officer | Gift | 4,000 | $0.00 |
| 2026-08-14 | Teichmann Sarah A. | Reporting person | Open market sale | 2,273 | $57.15 |
| 2026-08-13 | Teichmann Sarah A. | Reporting person | Open market sale | 5,278 | $57.29 |
| 2026-08-11 | STUELPNAGEL JOHN R | Reporting person | Open market sale | 17,000 | $57.58 |
| 2026-08-11 | STUELPNAGEL JOHN R | Reporting person | Open market sale | 3,000 | $58.73 |
| 2026-06-22 | Saxonov Serge | Chief Executive Officer | Open market sale | 8,527 | $33.29 |
| 2026-06-22 | Saxonov Serge | Chief Executive Officer | Open market sale | 9,991 | $34.28 |
| 2026-06-22 | Saxonov Serge | Chief Executive Officer | Open market sale | 9,821 | $35.32 |
| 2026-06-22 | Saxonov Serge | Chief Executive Officer | Open market sale | 1,661 | $36.16 |
| 2026-06-16 | SULIMAN SHEHNAAZ | Reporting person | Open market sale | 5,359 | $32.59 |
| 2026-06-16 | SULIMAN SHEHNAAZ | Reporting person | Open market sale | 364 | $33.27 |
| 2026-06-04 | Teichmann Sarah A. | Reporting person | Grant / award | 8,829 | $0.00 |
| 2026-06-04 | SULIMAN SHEHNAAZ | Reporting person | Grant / award | 8,829 | $0.00 |
| 2026-06-04 | STUELPNAGEL JOHN R | Reporting person | Grant / award | 8,829 | $0.00 |
| 2026-06-04 | Popovits Kimberly J | Reporting person | Grant / award | 8,829 | $0.00 |
| 2026-06-04 | MATEO ALAN | Reporting person | Grant / award | 8,829 | $0.00 |
| 2026-06-04 | Kosaraju Sridhar | Reporting person | Grant / award | 8,829 | $0.00 |
| 2026-05-26 | Saxonov Serge | Chief Executive Officer | Open market sale | 10,718 | $24.71 |
| 2026-05-22 | Saxonov Serge | Chief Executive Officer | Open market sale | 18,175 | $24.44 |
| 2026-05-22 | Hindson Benjamin J. | See Remarks | Open market sale | 11,595 | $24.44 |
| 2026-05-22 | Taich Adam | Chief Financial Officer | Open market sale | 15,098 | $24.44 |
| 2026-04-14 | Saxonov Serge | Chief Executive Officer | Open market sale | 5,000 | $24.56 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 02:19 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-24 | 4 | 2026-09-22 | View on SEC.gov → |
| 2026-09-24 | 4 | 2026-09-22 | View on SEC.gov → |
| 2026-09-11 | 4 | 2026-09-09 | View on SEC.gov → |
| 2026-09-08 | 4 | 2026-09-03 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-08-28 | 4 | 2026-08-26 | View on SEC.gov → |
| 2026-08-26 | 4 | 2026-08-24 | View on SEC.gov → |
| 2026-08-26 | 4 | 2026-08-24 | View on SEC.gov → |
| 2026-08-26 | 4 | 2026-08-24 | View on SEC.gov → |
| 2026-08-26 | 4 | 2026-08-24 | View on SEC.gov → |
| 2026-08-24 | 4 | 2026-08-20 | View on SEC.gov → |
| 2026-08-17 | 4 | 2026-08-13 | View on SEC.gov → |
Recent news
Headlines about TXG (10x Genomics, Inc. Class A). Links open the publisher — we don’t host full articles.
-
10x Genomics Inc (TXG) Shares Surge 5.8% -- What GF Score of 57 Tells Investors
GuruFocus · 2026-10-21 -
TXG rises as recent product rollout, partnerships and analyst target hikes keep momentum alive
Quiver Quantitative · 2026-10-21 -
TXG Feb 2027 70.000 put (TXG270219P00070000) interactive stock chart
Yahoo Finance Australia · 2026-10-21 -
TXG May 2027 70.000 put (TXG270521P00070000) stock price, news, quote and history
Yahoo Finance UK · 2026-10-21 -
TXG May 2027 70.000 put (TXG270521P00070000) interactive stock chart
Yahoo Finance Australia · 2026-10-21 -
10x Genomics, Inc. (TXG) stock price, news, quote and history
Yahoo Finance UK · 2026-10-20 -
10x Genomics, Inc. (TXG) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-20 -
Torex Gold Resources (TSX:TXG) Reaffirms Guidance As Valuation Debate Stays In Focus
Simply Wall Street · 2026-10-20
No headlines in this category right now — try “All”.